May 14, 2026

Glooko Announces FDA 510(k) Clearance for EndoTool IV Cloud

Glooko announced that the U.S. Food and Drug Administration has granted 510(k) clearance for EndoTool IV Cloud for patient-specific insulin dosing in hospitals.

Read More

May 12, 2026

Glooko and mylife Diabetes Care Expand Diabetes Data Management Partnership

Through an expanded partnership between Glooko and mylife Diabetes Care, Glooko will serve as the primary data management provider for mylife products.

Read More

May 7, 2026

Glooko Wins “Best Overall MedTech Software” in 2026 MedTech Breakthrough Awards

Glooko is the winner of the 2026 MedTech Breakthrough ‘Best Overall MedTech Software’ award for its diabetes and glycemic management software portfolio.

Read More

May 4, 2026

Mark Clements of Glooko recognized on Becker’s Healthcare’s 2026 ‘Great leaders in healthcare’ list

Glooko announced that Chief Medical and Strategy Officer Mark Clements, M.D., Ph.D., was named one of Becker's Healthcare's 2026 'Great leaders in healthcare.'

Read More

April 23, 2026

New EndoTool IV data presented at AACE show virtual elimination of severe hypoglycemia across 19 hospitals

Glooko revealed new data at AACE 2026 that demonstrated virtual elimination of severe hypoglycemia across 19 hospitals using EndoTool IV.

Read More

March 10, 2026

Glooko to Expand EMEA CGM Connectivity with Roche Accu-Chek® SmartGuide Integration

The Glooko diabetes management platform will integrate with the Roche Accu-Chek SmartGuide CGM solution across select European countries.

Read More